Physician profile
Kevin Chan
NPI 1225461981
$89,003.63
in general payments reported to CMS, 2019-2025
9 companies · $10K in 2025
The $10K reported for 2025 was more than what 99% of Pediatrics (Optometrist) providers received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $1,039 · 2021: $11K · 2022: $41K · 2023: $13K · 2024: $13K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Food and Beverage: $2,041 · Consulting Fee: $1,894 · Honoraria: $1,800 · Travel and Lodging: $1,441 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,125.00 |
| Food and Beverage | $2,041.17 |
| Consulting Fee | $1,893.75 |
| Honoraria | $1,800.00 |
| Travel and Lodging | $1,441.16 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oculus, INC. | $58,238.78 | 2019-2025 | Pentacam, Na |
| Johnson & Johnson Vision Care, INC. | $23,354.64 | 2021-2025 | Acuvue |
| Topcon Healthcare, INC. | $4,041.66 | 2023-2024 | |
| Visioneering Technologies, INC. | $1,534.91 | 2020-2023 | |
| Coopervision INC. | $839.61 | 2019-2025 | Misight Contact Lens, Paragon Crt |
| Bausch & Lomb Americas INC. | $669.31 | 2024 | Xiidra, Miebo, Infuse |
| Tarsus Pharmaceuticals, INC. | $167.76 | 2024-2025 | |
| Dompe US, INC. | $118.16 | 2024 | Oxervate |
| Carl Zeiss Meditec Ag | $38.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.